{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:40:19Z","timestamp":1775094019191,"version":"3.50.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.cll.2005.01.003","type":"journal-article","created":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T11:41:09Z","timestamp":1114083669000},"page":"259-277","source":"Crossref","is-referenced-by-count":57,"title":["Molecular Genetics of Familial Renal Cell Carcinoma Syndromes"],"prefix":"10.1016","volume":"25","author":[{"given":"David","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2005.01.003_bib1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJM199609193351207","article-title":"Renal-cell carcinoma","volume":"335","author":"Motzer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2005.01.003_bib2","series-title":"Pathology and genetics: tumours of the urinary system and male genital organs","first-page":"9","article-title":"Tumours of the kidney","author":"Eble","year":"2004"},{"key":"10.1016\/j.cll.2005.01.003_bib3","series-title":"The metabolic and molecular bases of inherited disease","first-page":"907","article-title":"Renal cell carcinoma","author":"Linehan","year":"2001"},{"key":"10.1016\/j.cll.2005.01.003_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0022-5347(05)66524-X","article-title":"Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience","volume":"165","author":"Herring","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.cll.2005.01.003_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.27.5.311","article-title":"Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma","volume":"27","author":"Maher","year":"1990","journal-title":"J Med Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.33.2.120","article-title":"A genetic register for von Hippel-Lindau disease","volume":"33","author":"Maddock","year":"1996","journal-title":"J Med Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","article-title":"von Hippel-Lindau disease","volume":"76","author":"Maher","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cll.2005.01.003_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00005392-199501000-00009","article-title":"Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications","volume":"153","author":"Poston","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.cll.2005.01.003_bib9","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0022-5347(01)62509-6","article-title":"Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma","volume":"160","author":"Neumann","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.cll.2005.01.003_bib10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cll.2005.01.003_bib11","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/sj.onc.1202473","article-title":"Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity","volume":"18","author":"Blankenship","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.cll.2005.01.003_bib12","doi-asserted-by":"crossref","first-page":"11661","DOI":"10.1073\/pnas.95.20.11661","article-title":"pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation","volume":"95","author":"Iliopoulos","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cll.2005.01.003_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0046-8177(97)90035-6","article-title":"Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues","volume":"28","author":"Corless","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cll.2005.01.003_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1003554712386","article-title":"Expression of von Hippel-Lindau protein in normal and pathological human tissues","volume":"31","author":"Sakashita","year":"1999","journal-title":"Histochem J"},{"key":"10.1016\/j.cll.2005.01.003_bib15","first-page":"231","article-title":"Expression pattern of the von Hippel-Lindau protein in human tissues","volume":"75","author":"Los","year":"1996","journal-title":"Lab Invest"},{"key":"10.1016\/j.cll.2005.01.003_bib16","first-page":"765","article-title":"Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors","volume":"60","author":"Prowse","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib18","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/3.12.2169","article-title":"Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma","volume":"3","author":"Foster","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib19","first-page":"1942","article-title":"VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation","volume":"60","author":"Brauch","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.01.003_bib20","doi-asserted-by":"crossref","first-page":"9700","DOI":"10.1073\/pnas.91.21.9700","article-title":"Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma","volume":"91","author":"Herman","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cll.2005.01.003_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2796.1998.00336.x","article-title":"Genotype-phenotype correlations in von Hippel-Lindau disease","volume":"243","author":"Neumann","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.cll.2005.01.003_bib22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<424::AID-HUMU9>3.0.CO;2-H","article-title":"Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma","volume":"12","author":"Olschwang","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cll.2005.01.003_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","article-title":"Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan","volume":"8","author":"Zbar","year":"1996","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cll.2005.01.003_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/humu.10309","article-title":"Genetic characterization and structural analysis of VHL Spanish families to define genotype-phenotype correlations","volume":"23","author":"Ruiz-Llorente","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cll.2005.01.003_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/humu.20082","article-title":"Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions","volume":"24","author":"Gallou","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cll.2005.01.003_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/humu.10302","article-title":"Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location","volume":"23","author":"Maranchie","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cll.2005.01.003_bib27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/jmg.33.4.328","article-title":"Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations","volume":"33","author":"Maher","year":"1996","journal-title":"J Med Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMp030061","article-title":"The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer","volume":"349","author":"George","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2005.01.003_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0959-437X(02)00010-2","article-title":"The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer","volume":"13","author":"Kim","year":"2003","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.cll.2005.01.003_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein","volume":"2","author":"Ohh","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.cll.2005.01.003_bib31","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cll.2005.01.003_bib32","doi-asserted-by":"crossref","first-page":"8507","DOI":"10.1073\/pnas.97.15.8507","article-title":"Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products","volume":"97","author":"Schoenfeld","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cll.2005.01.003_bib33","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1371\/journal.pbio.0000083","article-title":"Inhibition of HIF2alpha Is Sufficient to Suppress pVHL-Defective Tumor Growth","volume":"1","author":"Kondo","year":"2003","journal-title":"PLoS Biol"},{"key":"10.1016\/j.cll.2005.01.003_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","article-title":"Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein","volume":"1","author":"Kondo","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cll.2005.01.003_bib35","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","article-title":"The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix","volume":"1","author":"Ohh","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.cll.2005.01.003_bib36","first-page":"4184","article-title":"Hippel-Lindau protein promotes the assembly of actin and vinculin and inhibits cell motility","volume":"61","author":"Kamada","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.01.003_bib37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/MCB.21.3.865-874.2001","article-title":"VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling","volume":"21","author":"Davidowitz","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cll.2005.01.003_bib38","first-page":"3014","article-title":"VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells","volume":"62","author":"Bindra","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.01.003_bib39","first-page":"3803","article-title":"Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease","volume":"62","author":"Zatyka","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.01.003_bib40","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1158\/0008-5472.CAN-03-3139","article-title":"Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications","volume":"64","author":"Rapisarda","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.01.003_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa021491","article-title":"A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer","volume":"349","author":"Yang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2005.01.003_bib42","first-page":"4819","article-title":"Effects of PTK787\/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model","volume":"60","author":"Drevs","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.01.003_bib43","first-page":"327","article-title":"In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic\/pharmacodynamic relationship","volume":"9","author":"Mendel","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cll.2005.01.003_bib44","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJM197909133011107","article-title":"Hereditary renal-cell carcinoma associated with a chromosomal translocation","volume":"301","author":"Cohen","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2005.01.003_bib45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)81034-X","article-title":"The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers","volume":"84","author":"Ohta","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cll.2005.01.003_bib46","first-page":"2946","article-title":"Absence or reduction of Fhit expression in most clear cell renal carcinomas","volume":"58","author":"Hadaczek","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.01.003_bib47","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1038\/sj.onc.1205437","article-title":"The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL in a common pathway","volume":"21","author":"Gemmill","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.cll.2005.01.003_bib48","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jnci\/91.13.1159","article-title":"Renal cell cancer: chromosome 3 translocations as risk factors","volume":"91","author":"van Kessel","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cll.2005.01.003_bib49","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/ijc.2910430313","article-title":"Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas","volume":"43","author":"Kovacs","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2005.01.003_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1523-1755.1998.00762.x","article-title":"A familial case of renal cell carcinoma and a t(2;3) chromosome translocation","volume":"53","author":"Koolen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.cll.2005.01.003_bib51","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s100380170001","article-title":"Characterization of a familial RCC-associated t(2;3)(q33;q21) chromosome translocation","volume":"46","author":"Podolski","year":"2001","journal-title":"J Hum Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/jmg.38.3.165","article-title":"Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma","volume":"38","author":"Kanayama","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/gcc.1114","article-title":"Molecular analysis of a familial case of renal cell cancer and a t(3;6)(q12;q15)","volume":"31","author":"Eleveld","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cll.2005.01.003_bib54","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(05)61751-5","article-title":"Familial non-VHL non-papillary clear-cell renal cancer","volume":"349","author":"Teh","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2005.01.003_bib55","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jmg.37.5.348","article-title":"Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes","volume":"37","author":"Woodward","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib56","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.ju.0000096060.92397.ed","article-title":"The genetic basis of cancer of the kidney","volume":"170","author":"Linehan","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.cll.2005.01.003_bib57","first-page":"537","article-title":"Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors","volume":"10","author":"Delahunt","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2005.01.003_bib58","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ju.0000052373.36963.12","article-title":"Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden","volume":"169","author":"Czene","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.cll.2005.01.003_bib59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib60","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1097-2765(01)00261-1","article-title":"Coupling Met to specific pathways results in distinct developmental outcomes","volume":"7","author":"Maina","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.cll.2005.01.003_bib61","first-page":"645","article-title":"Met signaling mutants as tools for developmental studies","volume":"44","author":"Ponzetto","year":"2000","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.cll.2005.01.003_bib62","first-page":"1997","article-title":"Expression of the Met\/HGF receptor in normal and neoplastic human tissues","volume":"6","author":"Di Renzo","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.cll.2005.01.003_bib63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/A:1023768811842","article-title":"c-Met: structure, functions and potential for therapeutic inhibition","volume":"22","author":"Ma","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.cll.2005.01.003_bib64","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1073\/pnas.94.21.11445","article-title":"Activating mutations for the met tyrosine kinase receptor in human cancer","volume":"94","author":"Jeffers","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cll.2005.01.003_bib65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/1727","article-title":"Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas","volume":"20","author":"Zhuang","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib66","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/003655900750016779","article-title":"Precancerous lesions in the kidney","volume":"205","author":"Van Poppel","year":"2000","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1016\/j.cll.2005.01.003_bib67","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1074\/jbc.271.7.3615","article-title":"Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator","volume":"271","author":"Miyazawa","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cll.2005.01.003_bib68","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/01.ju.0000092861.21122.d2","article-title":"Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma","volume":"171","author":"Yamauchi","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.cll.2005.01.003_bib69","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cll.2005.01.003_bib70","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-9440(10)61757-9","article-title":"Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology","volume":"159","author":"Kiuru","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cll.2005.01.003_bib71","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/hmg\/ddg148","article-title":"Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency","volume":"12","author":"Alam","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9440(10)63091-X","article-title":"Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors","volume":"164","author":"Lehtonen","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cll.2005.01.003_bib73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.pcan.4500616","article-title":"Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer","volume":"6","author":"Bevan","year":"2003","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.cll.2005.01.003_bib75","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1357-2725(01)00143-1","article-title":"Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation\/death","volume":"34","author":"Mates","year":"2002","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cll.2005.01.003_bib76","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt-Hogg-Dube syndrome","volume":"26","author":"Pavlovich","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cll.2005.01.003_bib77","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1086\/323744","article-title":"Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2","volume":"69","author":"Schmidt","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib78","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/modpathol.3800152","article-title":"Expression of Birt-Hogg-Dube gene mRNA in normal and neoplastic human tissues","volume":"17","author":"Warren","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2005.01.003_bib79","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","article-title":"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome","volume":"2","author":"Nickerson","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cll.2005.01.003_bib80","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ijc.11694","article-title":"Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma","volume":"109","author":"Nagy","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2005.01.003_bib81","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jmg.40.11.820","article-title":"Analysis of the Birt-Hogg-Dube (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer","volume":"40","author":"da Silva","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib82","first-page":"4583","article-title":"Inactivation of BHD in sporadic renal tumors","volume":"63","author":"Khoo","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.01.003_bib83","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-5347(01)62888-X","article-title":"Familial renal oncocytoma: clinicopathological study of 5 families","volume":"160","author":"Weirich","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.cll.2005.01.003_bib84","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-230X(08)60742-3","article-title":"Inherited carcinomas of the kidney","volume":"75","author":"Zbar","year":"1998","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.cll.2005.01.003_bib85","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0094-0143(03)00023-5","article-title":"The genetic basis of renal cell carcinoma","volume":"30","author":"Pavlovich","year":"2003","journal-title":"Urol Clin N Am"},{"key":"10.1016\/j.cll.2005.01.003_bib86","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archderm.135.10.1195","article-title":"Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia","volume":"135","author":"Toro","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cll.2005.01.003_bib87","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/(SICI)1098-2264(199803)21:3<260::AID-GCC12>3.0.CO;2-T","article-title":"Bilateral multiple renal oncocytomas and cysts associated with a constitutional translocation (8;9)(q24.1;q34.3) and a rare constitutional VHL missense substitution","volume":"21","author":"Teh","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cll.2005.01.003_bib88","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1357-4310(98)01245-3","article-title":"The genetic basis of tuberous sclerosis","volume":"4","author":"Young","year":"1998","journal-title":"Mol Med Today"},{"key":"10.1016\/j.cll.2005.01.003_bib89","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/modpathol.3880275","article-title":"Concurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases","volume":"14","author":"Jimenez","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2005.01.003_bib90","first-page":"1201","article-title":"Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features","volume":"149","author":"Bjornsson","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cll.2005.01.003_bib91","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"The European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.cll.2005.01.003_bib92","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cll.2005.01.003_bib93","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/35010550","article-title":"The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho","volume":"2","author":"Lamb","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.cll.2005.01.003_bib94","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/hmg\/7.6.1053","article-title":"Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products","volume":"7","author":"van Slegtenhorst","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cll.2005.01.003_bib95","doi-asserted-by":"crossref","first-page":"35647","DOI":"10.1074\/jbc.274.50.35647","article-title":"Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin","volume":"274","author":"Nellist","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cll.2005.01.003_bib96","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tcb.2003.12.006","article-title":"Tuberous sclerosis complex: from Drosophila to human disease","volume":"14","author":"Pan","year":"2004","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.cll.2005.01.003_bib97","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","article-title":"TSC2 regulates VEGF through mTOR-dependent and -independent pathways","volume":"4","author":"Brugarolas","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cll.2005.01.003_bib98","first-page":"2675","article-title":"Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene","volume":"63","author":"Liu","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.01.003_bib99","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1210\/jc.85.5.1758","article-title":"Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome","volume":"85","author":"Malchoff","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271205000041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271205000041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T01:28:36Z","timestamp":1548552516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271205000041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0272271205000041"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2005.01.003","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}